기타 스킬

Deprecated alias — use `/woz share`.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Deprecated alias — use `/woz review`.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Deprecated alias — use `/woz-kb <op>` (e.g. `/woz-kb status`).

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Deprecated alias — use `/woz benchmark`.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Guided setup and upgrade-check experience for Lattice projects -- scans the repository, detects existing configuration and outdated conventions, suggests refiners and available upgrades in priority order, and creates or reconciles the .lattice/ config. Bridges the gap between installing skills and getting first value, and between upgrading Lattice and adopting its newest conventions. Use when the user says 'lattice init', 'set up lattice', 'initialize lattice', 'get started with lattice', 'configure lattice for this project', 'check for lattice upgrades', or 'upgrade lattice conventions'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Facilitate a structured conversation to define architecture principles for a repository. Supports multiple architecture styles: clean architecture (default), hexagonal / ports & adapters, modular monolith, or custom. Produces a formal architecture document that the corresponding atom will use. Use when setting up a new project, defining architecture standards, or when the user says 'setup architecture', 'define layers', 'architecture principles', 'help me define my architecture', 'hexagonal architecture', 'modular monolith', 'ports and adapters', or 'define my architecture style'.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Valuation methods analysis, DCF inputs, comparable multiples, P/E ratio, EV/EBITDA, price to book, valuation assumptions, relative valuation, intrinsic value, fair value estimate

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Secular technology trends, technology adoption cycle, disruption risk, AI impact analysis, digital transformation, industry 4.0 trends, technology moat, innovation trajectory, R&D effectiveness, tech competitive positioning

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Risk analysis, regulatory risk assessment, competitive risk, macro risk, technology risk, litigation risk, financial risk assessment, enterprise risk, operational risk, geopolitical risk exposure

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Recent quarter performance analysis, quarterly earnings review, last quarter results, quarterly financial performance, analyze recent quarter, Q4 earnings, quarterly revenue breakdown, EPS this quarter, margin analysis recent quarter, sequential growth, quarterly performance review

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Competitive landscape analysis, competitor comparison, peer positioning, market share dynamics, competitive moat assessment, Porter five forces, industry competition, competitive advantage analysis, market positioning, strategic group mapping, compare competitors

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Med-sector overview across med.medicines_biotech and med.medical_devices with med trends, catalysts, FDA-decision context, and a cross-sector ripple map (quantified sign/magnitude per name). Use to frame any biotech/pharma/device analysis before diving into a single name.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Med-adapted recent-quarter review: last print financials, pipeline-milestone awareness, and FDA-event context — reads the quarter through the med lens (milestones moved, runway, regulatory updates) rather than generic financials alone.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Med peer benchmarking: select actual biotech/pharma peers via the med universe (drug/indication overlap where possible) and compare med-relevant metrics — pipeline depth, catalyst density, cash position, margins, valuation multiples.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Patient-flow market sizing for med products — prevalence → diagnosed → interested → affordable → covered → treated → persistent, priced as price × duration per cohort, with capacity constraints, named historical analog anchoring, and always bull/base/bear named-driver grids. Use to size a therapy area or product market before any valuation or share work.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Post-event analyst note (conferences, KOL events, site visits) with the professional note anatomy — headline verdict, per-stock takeaways with model numbers, KOL distillation, cross-trial comparison lattices, modeled deltas vs consensus (peak × POS), three what's-changed vectors, risk bullets, and materiality-rated conflicting views. Use after any med event to convert the event into actionable takeaways.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Medicines pipeline analysis over structured universes: Phase I-III assets with probability-of-success discipline (unadjusted peak x POS = modeled value; POS changes logged with reasons), trial status-diff tracking, and mechanism/competitor mapping via drug-knowledge lookups.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

CDER-track catalyst analysis for medicines: PDUFA target dates, AdCom votes, sNDA/sBLA label expansions, biosimilar interchangeability and 180-day exclusivity, Orange Book state, and CRL remediation timelines — enumerated, verified, and sized per event for any biotech/pharma ticker or watchlist.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Device-track catalyst analysis: 510(k), PMA, and De Novo decision events, CMS coverage and NTAP milestones, recalls and watch actions as risk signals, and post-market surveillance obligations — dated, verified, and sized per event for any medtech ticker or watchlist.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Med-adapted earnings preview: consensus estimates, historical surprises, guidance sensitivities, and the FDA-catalyst overlay (PDUFA/AdCom/trial readouts near the print) for biotech/pharma names.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Find current job postings on employer career pages and job boards. Use when the user asks who's hiring, seeks remote or local jobs, or wants openings matched to their role, skills, experience, or salary preferences.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Monitor competitor pricing, features, changelogs, dashboards, and product changes with Firecrawl. Use for recurring competitive intelligence, pricing tier extraction, feature change tracking, or structured competitor alerts.

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Financial ratio analysis, profitability ratios ROE ROA ROIC, liquidity ratios current quick cash, leverage ratios debt-to-equity interest coverage, efficiency ratios asset turnover inventory turnover DSO, valuation ratios PE PB EV/EBITDA, cross-company ratio comparison, DuPont analysis

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.

Trade execution using price action setups, major trend reversal trading top and bottom, MTR failure continuation, strong bull and bear breakout trading, strong and weak channel trading strategies, trading range strategies, opening range swings, integration with gold.technical_setups for setup matching and execution planning

한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.